New England Journal of Medicine publishes findings of largest non-invasive prenatal testing (NIPT) study involving more than 18,500 expectant mothers "This landmark study supports the use of NIPT as a ...
New England Journal of Medicine publishes findings of largest non-invasive prenatal testing study involving more than 18,500 expectant mothers SAN JOSE, California, April 2 /PRNewswire/ -- Roche (SIX: ...
BioReference announced the acquisition of the U.S. Ariosa centralized laboratory prenatal testing business from Roche. Ariosa’s non invasive prenatal screening (NIPS) test, the Harmony Prenatal Test, ...
BioReference Laboratories Inc. in Elmwood Park acquired the U.S. Ariosa centralized laboratory prenatal testing business from Roche. The Harmony Prenatal Test, Ariosa’s non-invasive prenatal screening ...
Ariosa Diagnostics announced that its scientists have successfully tested and implemented a microarray DNA quantification method for Ariosa's Harmony Non-Invasive Prenatal Test SAN JOSE, California, ...
OPKO Health, Inc.’s OPK subsidiary – BioReference Laboratories, Inc. – recently announced the buyout of the U.S. Ariosa centralized laboratory prenatal testing business from Roche Holding AG RHHBY. It ...
Pregnancy can be incredibly difficult, especially since it’s hard to know what’s really happening to the fetus. Thankfully, the Harmony prenatal test can help. It’s a noninvasive prenatal test for ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix (Nasdaq:AFFX) and Ariosa Diagnostics, Inc. today announced the signing of a multi-year supply agreement covering Affymetrix arrays and instruments to ...
Ariosa's non invasive prenatal screening (NIPS) test, the Harmony Prenatal Test, is one of the most widely studied tests utilized in prenatal screening. The test has been performed in over 1.5 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results